It has been found that 54 percent (13/24) of clinically localized prostatic carcinomas and 4 out of 4 metastatic carcinomas had allelic loss of at least one of the following chromosomal loci: 3p, 7q, 9q, 10q, 11q, 13q, 16q, 17p, and 18q. Chromosome loci 10q and 16q had the highest frequency of allelic loss, with 30% of prostate cancers showing these defects, suggesting that 10q and 16q contain tumor suppressor genes important for regulation of prostatic cell proliferation.
Losses of a portion of chromosome 11p in prostate cancer are close to but do not include the Wilms? tumor gene locus WT-1. A provocative additional finding in this latter study was that introduction of human chromosome 11 into highly metastatic rat prostate cells by somatic cell hybridization suppressed the metastatic potential of the hybrid cells without suppression of in vivo growth or tumorigenicity of the cells.
The p53 gene is also altered in prostatic cancer. A high level of p53 expression, presumably of a mutated form, has been reported for prostatic carcinomas of high histologic grade with chromosomal aneuploidy and a high cell proliferation rate. Patients with high levels of in their tumors had a significantly poorer survival rate.
Pancreatic tumors most often metastisize to the lower lumbar vertebrae causing pathological fracturing. This is a high-yield fact you need to know for the USMLE.
justin timberlake engaged bluefin tuna jonestown hayden panettiere john dillinger atlanta hawks carlos zambrano
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.